(PLD) Prologis - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US74340W1036
Stock: Warehouses, Distribution Centers, Logistics Facilities
Total Rating 50
Risk 52
Buy Signal -0.04
| Risk 5d forecast | |
|---|---|
| Volatility | 25.6% |
| Relative Tail Risk | -4.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | 1.45 |
| Character TTM | |
|---|---|
| Beta | 0.698 |
| Beta Downside | 0.956 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.37% |
| CAGR/Max DD | 0.23 |
EPS (Earnings per Share)
Revenue
Description: PLD Prologis March 04, 2026
Prologis, Inc. (PLD) is a leading global logistics real estate investment trust (REIT). The company specializes in high-barrier, high-growth markets, reflecting the increasing demand for efficient supply chain infrastructure.
As of September 30, 2025, Prologiss portfolio included approximately 1.3 billion square feet across 20 countries. Its business model involves leasing modern logistics facilities to about 6,500 customers, primarily in business-to-business and retail/online fulfillment sectors. These sectors are key drivers of demand for industrial real estate.
To understand the full scope of their market position and financial health, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- E-commerce growth fuels demand for logistics facilities
- Industrial real estate cap rates impact property valuations
- Interest rate changes affect borrowing costs and investment returns
- Global supply chain disruptions increase warehouse utilization
- Tenant retention and new lease rates drive rental income
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 3.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.28 > 1.0 |
| NWC/Revenue: -52.15% < 20% (prev -2.68%; Δ -49.48% < -1%) |
| CFO/TA 0.05 > 3% & CFO 5.01b > Net Income 3.33b |
| Net Debt (33.89b) to EBITDA (7.20b): 4.71 < 3 |
| Current Ratio: 0.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (958.0m) vs 12m ago 0.46% < -2% |
| Gross Margin: 59.60% > 18% (prev 0.75%; Δ 5.88k% > 0.5%) |
| Asset Turnover: 9.06% > 50% (prev 8.60%; Δ 0.46% > 0%) |
| Interest Coverage Ratio: 4.56 > 6 (EBITDA TTM 7.20b / Interest Expense TTM 1.00b) |
Altman Z'' -0.07
| A: -0.05 (Total Current Assets 1.35b - Total Current Liabilities 5.93b) / Total Assets 98.72b |
| B: -0.01 (Retained Earnings -1.36b / Total Assets 98.72b) |
| C: 0.05 (EBIT TTM 4.57b / Avg Total Assets 97.03b) |
| D: -0.04 (Book Value of Equity -1.53b / Total Liabilities 40.97b) |
| Altman-Z'' Score: -0.07 = B |
Beneish M -3.33
| DSRI: 0.90 (Receivables 601.3m/624.5m, Revenue 8.79b/8.20b) |
| GMI: 1.26 (GM 59.60% / 74.92%) |
| AQI: 0.18 (AQ_t 0.17 / AQ_t-1 0.96) |
| SGI: 1.07 (Revenue 8.79b / 8.20b) |
| TATA: -0.02 (NI 3.33b - CFO 5.01b) / TA 98.72b) |
| Beneish M-Score: -3.33 (Cap -4..+1) = AA |
What is the price of PLD shares?
As of March 15, 2026, the stock is trading at USD 134.40 with a total of 2,766,703 shares traded.
Over the past week, the price has changed by -2.07%, over one month by -5.20%, over three months by +0.83% and over the past year by +23.63%.
Over the past week, the price has changed by -2.07%, over one month by -5.20%, over three months by +0.83% and over the past year by +23.63%.
Is PLD a buy, sell or hold?
Prologis has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy PLD.
- StrongBuy: 9
- Buy: 5
- Hold: 8
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the PLD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 141.8 | 5.5% |
| Analysts Target Price | 141.8 | 5.5% |
PLD Fundamental Data Overview March 11, 2026
P/E Trailing = 37.8571
P/E Forward = 52.6316
P/S = 13.6663
P/B = 2.3539
P/EG = 175.2507
Revenue TTM = 8.79b USD
EBIT TTM = 4.57b USD
EBITDA TTM = 7.20b USD
Long Term Debt = 35.04b USD (from longTermDebt, last quarter)
Short Term Debt = 44.7m USD (from shortLongTermDebt, last quarter)
Debt = 35.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 33.89b USD (from netDebt column, last quarter)
Enterprise Value = 159.52b USD (125.63b + Debt 35.04b - CCE 1.15b)
Interest Coverage Ratio = 4.56 (Ebit TTM 4.57b / Interest Expense TTM 1.00b)
EV/FCF = 31.85x (Enterprise Value 159.52b / FCF TTM 5.01b)
FCF Yield = 3.14% (FCF TTM 5.01b / Enterprise Value 159.52b)
FCF Margin = 56.98% (FCF TTM 5.01b / Revenue TTM 8.79b)
Net Margin = 37.86% (Net Income TTM 3.33b / Revenue TTM 8.79b)
Gross Margin = 59.60% ((Revenue TTM 8.79b - Cost of Revenue TTM 3.55b) / Revenue TTM)
Gross Margin QoQ = 44.62% (prev 45.71%)
Tobins Q-Ratio = 1.62 (Enterprise Value 159.52b / Total Assets 98.72b)
Interest Expense / Debt = 0.74% (Interest Expense 260.5m / Debt 35.04b)
Taxrate = 5.28% (82.7m / 1.56b)
NOPAT = 4.33b (EBIT 4.57b * (1 - 5.28%))
Current Ratio = 0.23 (Total Current Assets 1.35b / Total Current Liabilities 5.93b)
Debt / Equity = 0.66 (Debt 35.04b / totalStockholderEquity, last quarter 53.19b)
Debt / EBITDA = 4.71 (Net Debt 33.89b / EBITDA 7.20b)
Debt / FCF = 6.77 (Net Debt 33.89b / FCF TTM 5.01b)
Total Stockholder Equity = 53.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.43% (Net Income 3.33b / Total Assets 98.72b)
RoE = 6.28% (Net Income TTM 3.33b / Total Stockholder Equity 53.01b)
RoCE = 5.19% (EBIT 4.57b / Capital Employed (Equity 53.01b + L.T.Debt 35.04b))
RoIC = 4.96% (NOPAT 4.33b / Invested Capital 87.26b)
WACC = 6.79% (E(125.63b)/V(160.67b) * Re(8.49%) + D(35.04b)/V(160.67b) * Rd(0.74%) * (1-Tc(0.05)))
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.29%
[DCF] Terminal Value 84.17% ; FCFF base≈4.83b ; Y1≈5.50b ; Y5≈7.54b
[DCF] Fair Price = 146.9 (EV 170.47b - Net Debt 33.89b = Equity 136.58b / Shares 929.6m; r=6.79% [WACC]; 5y FCF grow 16.09% → 2.90% )
EPS Correlation: -3.24 | EPS CAGR: -0.18% | SUE: 2.99 | # QB: 1
Revenue Correlation: 77.55 | Revenue CAGR: 17.79% | SUE: 1.65 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.76 | Chg7d=-0.009 | Chg30d=+0.049 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-12-31): EPS=2.99 | Chg7d=+0.000 | Chg30d=+0.077 | Revisions Net=-1 | Growth EPS=-16.1% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=3.35 | Chg7d=+0.000 | Chg30d=+0.050 | Revisions Net=+0 | Growth EPS=+11.9% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 8.5% - Earnings Yield 2.6%)
[Growth] Growth Spread = +0.5% (Analyst 6.4% - Implied 5.8%)
P/E Forward = 52.6316
P/S = 13.6663
P/B = 2.3539
P/EG = 175.2507
Revenue TTM = 8.79b USD
EBIT TTM = 4.57b USD
EBITDA TTM = 7.20b USD
Long Term Debt = 35.04b USD (from longTermDebt, last quarter)
Short Term Debt = 44.7m USD (from shortLongTermDebt, last quarter)
Debt = 35.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 33.89b USD (from netDebt column, last quarter)
Enterprise Value = 159.52b USD (125.63b + Debt 35.04b - CCE 1.15b)
Interest Coverage Ratio = 4.56 (Ebit TTM 4.57b / Interest Expense TTM 1.00b)
EV/FCF = 31.85x (Enterprise Value 159.52b / FCF TTM 5.01b)
FCF Yield = 3.14% (FCF TTM 5.01b / Enterprise Value 159.52b)
FCF Margin = 56.98% (FCF TTM 5.01b / Revenue TTM 8.79b)
Net Margin = 37.86% (Net Income TTM 3.33b / Revenue TTM 8.79b)
Gross Margin = 59.60% ((Revenue TTM 8.79b - Cost of Revenue TTM 3.55b) / Revenue TTM)
Gross Margin QoQ = 44.62% (prev 45.71%)
Tobins Q-Ratio = 1.62 (Enterprise Value 159.52b / Total Assets 98.72b)
Interest Expense / Debt = 0.74% (Interest Expense 260.5m / Debt 35.04b)
Taxrate = 5.28% (82.7m / 1.56b)
NOPAT = 4.33b (EBIT 4.57b * (1 - 5.28%))
Current Ratio = 0.23 (Total Current Assets 1.35b / Total Current Liabilities 5.93b)
Debt / Equity = 0.66 (Debt 35.04b / totalStockholderEquity, last quarter 53.19b)
Debt / EBITDA = 4.71 (Net Debt 33.89b / EBITDA 7.20b)
Debt / FCF = 6.77 (Net Debt 33.89b / FCF TTM 5.01b)
Total Stockholder Equity = 53.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.43% (Net Income 3.33b / Total Assets 98.72b)
RoE = 6.28% (Net Income TTM 3.33b / Total Stockholder Equity 53.01b)
RoCE = 5.19% (EBIT 4.57b / Capital Employed (Equity 53.01b + L.T.Debt 35.04b))
RoIC = 4.96% (NOPAT 4.33b / Invested Capital 87.26b)
WACC = 6.79% (E(125.63b)/V(160.67b) * Re(8.49%) + D(35.04b)/V(160.67b) * Rd(0.74%) * (1-Tc(0.05)))
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.29%
[DCF] Terminal Value 84.17% ; FCFF base≈4.83b ; Y1≈5.50b ; Y5≈7.54b
[DCF] Fair Price = 146.9 (EV 170.47b - Net Debt 33.89b = Equity 136.58b / Shares 929.6m; r=6.79% [WACC]; 5y FCF grow 16.09% → 2.90% )
EPS Correlation: -3.24 | EPS CAGR: -0.18% | SUE: 2.99 | # QB: 1
Revenue Correlation: 77.55 | Revenue CAGR: 17.79% | SUE: 1.65 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.76 | Chg7d=-0.009 | Chg30d=+0.049 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-12-31): EPS=2.99 | Chg7d=+0.000 | Chg30d=+0.077 | Revisions Net=-1 | Growth EPS=-16.1% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=3.35 | Chg7d=+0.000 | Chg30d=+0.050 | Revisions Net=+0 | Growth EPS=+11.9% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 8.5% - Earnings Yield 2.6%)
[Growth] Growth Spread = +0.5% (Analyst 6.4% - Implied 5.8%)